MedTrace Logo

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

NCT05388682 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-12-20

No results posted yet for this study

Summary

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement
2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Conditions

  • Takayasu Arteritis With Pulmonary Artery Involvement
  • Percutaneous Transluminal Pulmonary Angioplasty
  • PAH Targeted Medication

Interventions

DEVICE

Percutaneous transluminal pulmonary angioplasty

Percutaneous transluminal pulmonary angioplasty

Sponsors & Collaborators

  • Chinese Pulmonary Vascular Disease Research Group

    lead OTHER

Principal Investigators

  • zhihong Liu, doctor · Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-19
Primary Completion
2042-12-31
Completion
2042-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05388682 on ClinicalTrials.gov